Table 6.
Rank | Reference | Citations | Author | Year | Type | Journal | IF | JCR |
---|---|---|---|---|---|---|---|---|
1 | CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors | 57 | Majzner Robbie G. | 2019 | Article | Clinical Cancer Research | 12.531 | Q1 |
2 | Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells | 46 | Du Hongwei | 2019 | Article | Cancer Cell | 31.743 | Q1 |
3 | B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma | 17 | Tang Xin | 2019 | Article | Molecular Therapy: Oncolytics | 7.200 | Q4 |
4 | B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres |
12 | Nehama Dean | 2019 | Article | EBioMedicine | 8.143 | Q2 |
5 | Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature | 11 | Seaman Steven | 2017 | Article | Cancer Cell | 31.743 | Q1 |
IF, impact factors; JCR, journal citation reports.